Helgason Laboratory (Leukaemia and Autophagy Therapeutics)

We focus on Bench to Bedside translational research. Our focus has been on Chronic Myeloid Leukaemia (CML), a tumour type in which Glasgow has particular clinical expertise and excising translational projects.

We are also interested in related leukaemias and myeloproliferative neoplasms, with the overall aim of targeting appropriate therapy to the stem cell compartment to remove the population in which drug resistance occurs. All on-going projects relate to targeting: Leukaemia Stem Cells, Autophagy, Cancer Metabolism, Leukaemia Niche.